KinN Therapeutics is a Bergen-based biopharmaceutical company focused on tailored preclinical oncology services for the development of novel anticancer compounds.

We have the preclinical cancer models needed to understand your cancer drug treatment. KinN specializes in xenograft models of cancer and tracking the progression over time. We have multiple in vivo and in vitro approaches to assess the effectiveness of drug treatments in various cancer types.